Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pelvic fracture study tests surgery vs. rehab in seniors

NCT ID NCT06496867

Knowledge-focused Sponsor: University of Southern California Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused This study
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 26, 2026 · Updated 3 times

Summary

This pilot study looks at two ways to treat a specific type of pelvic fracture in people aged 60 and older. One group gets early surgery to fix the bone, while the other group gets rehab without surgery. The main goal is to see if a larger study is possible, not to prove which treatment is better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 48 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patient 60 years of age or older. 2. Low energy injury mechanism defined as a fall from standing height. 3. LC1 pelvis fracture (AO/OTA 61B1.1 or 61B2.1) confirmed with antero-posterior, inlet, and outlet pelvis radiographs, computed tomography, or magnetic resonance imaging. 4. Fracture pattern that could be, in the judgment of the attending surgeon, managed with either early internal fixation or nonoperative care with early rehabilitation. 5. Fracture displacement of \<10 mm of the posterior pelvic ring on computed tomography of the pelvis. 6. Injury occurred within 21 days of screening. Exclusion Criteria: 1. Patient did not ambulate prior to injury. 2. Patient has another condition, injury, or fracture that prevents post-operative weightbearing on any extremity. 3. Retained implants around the pelvis that precludes or limits either study treatment. 4. Infection around the hip (soft tissue or bone). 5. Pathologic fracture with a lytic lesion in the pelvis or sacrum that precludes internal fixation. 6. Patient is too ill, in the judgement of the attending surgeon, for internal fixation. 7. Patient is too ill, in the judgement of the attending surgeon, for nonoperative care. 8. Problems, in the judgment of study personnel, with maintaining follow-up with the patient. 9. Expected injury survival of less than 12 months. 10. Terminal illness with expected survival of less than 12 months. 11. Currently enrolled in a study that does not permit co-enrollment. 12. Prior enrollment in the trial. 13. Unable to obtain informed consent due to language barriers. 14. Unable to obtain informed consent because a legally authorized representative (LAR) was unavailable. 15. Did not provide informed consent (declined participation). 16. Patient or LAR not approached to participate in the trial (missed patient). 17. Other reason to exclude the patient, as approved by the Methods Centre.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fragility fracture are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hip fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fragility fracture Internal fixation Multiple closed pelvic fractures with disruption of pelvic ring Nonoperative care

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    13 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cedars-Sinai Medical Center

    Los Angeles, California, 90048, United States

  • Indiana University

    Bloomington, Indiana, 47405, United States

  • Keck Medical Center of USC

    Los Angeles, California, 90033, United States

  • Los Angeles General Medical Center

    Los Angeles, California, 90033, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • Research Institute Vall d'Hebrón - Vall d'Hebron University Hospital

    Barcelona, Spain, 08035, Spain

  • The Curators of the University of Missouri - Missouri Orthopaedic Institute

    Columbia, Missouri, 65201, United States

  • University of Arizona

    Phoenix, Arizona, 85006, United States

  • University of California San Francisco

    San Francisco, California, 94143, United States

  • University of California, Davis

    Sacramento, California, 95817, United States

  • University of Maryland, Baltimore - R Adams Cowley Shock Trauma Center

    Baltimore, Maryland, 21201, United States

  • University of Utah

    Salt Lake City, Utah, 84112, United States

  • University of Washington - Harborview Medical Center

    Seattle, Washington, 98104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.